Alive Impex Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -14.50%
- Profit Growth 16.19%
- Ebitda -74.55%
- Net Worth 7.94%
- Total Assets -2.00%
About Alive Impex
Alive Impex Private Limited (AIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 June 2017 (Seven years and eight months 25 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Neera Dube and Sachendra Dube serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999GJ2017PTC097684
- Company No.
097684
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Alive Impex Private Limited offer?
Alive Impex Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Nutraceuticals & Dietary Supplements, Weight Gain Nutrition, Child and Baby Care Products, Baby Oil, Cosmetics, Hair & Beauty Products, Hair Care Cosmetics, Hand Sanitizers & Personal Hygiene, Beauty Soap.
Who are the key members and board of directors at Alive Impex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neera Dube  | Director | 01-Jun-2017 | Current |
| Sachendra Dube | Director | 26-May-2022 | Current |
Financial Performance of Alive Impex.
Alive Impex Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 14.5% decrease. The company also saw a substantial improvement in profitability, with a 16.19% increase in profit. The company's net worth moved up by a moderate rise of 7.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alive Impex?
In 2021, Alive Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Giniva Pharmaceuticals Private LimitedSachendra Dube is a mutual person
- Philos Pharma Private Limited
Sachendra Dube is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alive Impex?
Unlock and access historical data on people associated with Alive Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alive Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alive Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
